MVCAX
Price
$32.32
Change
+$0.09 (+0.28%)
Updated
Oct 8 closing price
Net Assets
17.12B
PMVEX
Price
$26.91
Change
+$0.08 (+0.30%)
Updated
Oct 8 closing price
Net Assets
165.78M
Interact to see
Advertisement

MVCAX vs PMVEX

Header iconMVCAX vs PMVEX Comparison
Open Charts MVCAX vs PMVEXBanner chart's image
MFS Mid Cap Value A
Price$32.32
Change+$0.09 (+0.28%)
VolumeN/A
Net Assets17.12B
PGIM Quant Solutions Mid-Cap Val R2
Price$26.91
Change+$0.08 (+0.30%)
VolumeN/A
Net Assets165.78M
MVCAX vs PMVEX Comparison Chart in %
View a ticker or compare two or three
VS
MVCAX vs. PMVEX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MVCAX is a Buy and PMVEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MVCAX has more cash in the bank: 17.1B vs. PMVEX (166M). PMVEX pays higher dividends than MVCAX: PMVEX (1.22) vs MVCAX (0.84). MVCAX was incepted earlier than PMVEX: MVCAX (24 years) vs PMVEX (8 years). PMVEX (25.08) is less costly to investors than MVCAX (1.00). PMVEX is a more actively managed with annual turnover of: 97.00 vs. MVCAX (27.00). PMVEX has a lower initial minimum investment than MVCAX: PMVEX (0) vs MVCAX (1000). PMVEX annual gain was more profitable for investors over the last year : 8.37 vs. MVCAX (-5.28). PMVEX return over 5 years is better than : 91.81 vs. MVCAX (46.13).
MVCAXPMVEXMVCAX / PMVEX
Total Expense Ratio0.991.2380%
Annual Report Gross Expense Ratio1.0025.084%
Fund Existence24 years8 years-
Gain YTD5.0529.10955%
Front Load6%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets17.1B166M10,301%
Annual Yield % from dividends0.841.2269%
Returns for 1 year-5.288.37-63%
Returns for 3 years24.3044.8754%
Returns for 5 years46.1391.8150%
Returns for 10 years73.84N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ECEMX17.03N/A
N/A
Parametric Emerging Markets C
LGPSX41.20N/A
N/A
ProFunds Large Cap Growth Svc
ITCTX26.37N/A
N/A
VY® T. Rowe Price Capital Apprec S2
BRXCX16.50N/A
N/A
MFS Blended Research Intl Eq C
WENRX67.79N/A
N/A
Allspring Mid Cap Growth Fund - Cl R6